• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与中草药相关的快速进展性纤维化间质性肾炎。

Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs.

作者信息

Yang C S, Lin C H, Chang S H, Hsu H C

机构信息

Department of Internal Medicine, Cathay General Hospital, Taipei, Taiwan.

出版信息

Am J Kidney Dis. 2000 Feb;35(2):313-8. doi: 10.1016/s0272-6386(00)70343-x.

DOI:10.1016/s0272-6386(00)70343-x
PMID:10676733
Abstract

Rapidly progressive fibrosing interstitial nephritis after a slimming regimen containing aristolochic acid has been identified as Chinese herbs nephropathy (CHNP). From 1995 to 1998, we observed 12 Chinese people from different areas of Taiwan who underwent renal biopsy for unexplained renal failure. Medical history gave no clue to the causes of impaired renal function except for the ingestion of traditional Chinese herbs. Although these patients ingested herbal drugs from various sources for different purposes, their renal biopsy samples showed amazingly similar histological findings, with extensive hypocellular interstitial fibrosis and atrophy and loss of tubules in all cases. Glomeruli were apparently intact. They also had similar clinical features, such as normal or mildly elevated blood pressure, early and severe anemia, low-grade proteinuria, glycosuria, and insignificant urinary sediments. Renal function deteriorated rapidly in most patients despite discontinuation of the herbal medicines. Seven patients underwent dialysis, and the remainder experienced slowly progressive renal failure. Bladder carcinoma was found in one patient. Morphologically and clinically, the nephropathy in our patients was similar to CHNP, reported in Belgium. Because of the complexity and unknown types of herbs used in different clinical situations, unidentified phytotoxins other than aristolochic acid might be responsible for this unique disease entity. We conclude that the relation of this nephropathy to the consumption of Chinese herbs is striking. Using uncontrolled herbal remedies carries a high risk for developing interstitial renal fibrosis and urothelial malignancy.

摘要

在服用含马兜铃酸的减肥疗法后出现的快速进展性纤维化间质性肾炎已被认定为中草药肾病(CHNP)。1995年至1998年,我们观察了12名来自台湾不同地区因不明原因肾衰竭接受肾活检的中国人。除了服用过传统中草药外,病史未提示肾功能损害的原因。尽管这些患者因不同目的服用了来源各异的草药,但他们的肾活检样本显示出惊人相似的组织学表现,所有病例均有广泛的细胞减少性间质纤维化以及肾小管萎缩和丧失。肾小球明显完整。他们也有相似的临床特征,如血压正常或轻度升高、早期严重贫血、轻度蛋白尿、糖尿以及尿沉渣不显著。尽管停用了草药,大多数患者的肾功能仍迅速恶化。7名患者接受了透析,其余患者则经历了缓慢进展的肾衰竭。1名患者发现患有膀胱癌。从形态学和临床角度来看,我们患者的肾病与比利时报道的CHNP相似。由于不同临床情况下使用的草药种类复杂且不明,除马兜铃酸外的未知植物毒素可能是导致这种独特疾病实体的原因。我们得出结论,这种肾病与食用中草药之间的关联十分显著。使用未受控制的草药疗法会有发生间质性肾纤维化和尿路上皮恶性肿瘤的高风险。

相似文献

1
Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs.与中草药相关的快速进展性纤维化间质性肾炎。
Am J Kidney Dis. 2000 Feb;35(2):313-8. doi: 10.1016/s0272-6386(00)70343-x.
2
Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications.与中草药相关的快速进展性间质性肾纤维化
Am J Nephrol. 2001 Nov-Dec;21(6):441-8. doi: 10.1159/000046647.
3
Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.马兜铃酸与“中草药肾病”:迄今证据综述
Drug Saf. 2003;26(1):33-48. doi: 10.2165/00002018-200326010-00004.
4
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.年轻女性快速进展性间质性肾纤维化:与包括中草药在内的减肥方案的关联。
Lancet. 1993 Feb 13;341(8842):387-91. doi: 10.1016/0140-6736(93)92984-2.
5
Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs.中药中马兜铃酸所致范科尼综合征、间质纤维化及肾衰竭
Pediatr Nephrol. 2006 Apr;21(4):577-9. doi: 10.1007/s00467-006-0017-6. Epub 2006 Mar 7.
6
Chinese herbal nephropathy and urothelial malignancy.中草药肾病与尿路上皮恶性肿瘤
J R Soc Promot Health. 2002 Dec;122(4):266-7. doi: 10.1177/146642400212200415.
7
[Aristolochic acid nephropathy].[马兜铃酸肾病]
Przegl Lek. 2009;66(5):253-6.
8
Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs.一种新描述的与长期使用中草药相关的肾病的病理学特征
Am J Kidney Dis. 1994 Aug;24(2):172-80. doi: 10.1016/s0272-6386(12)80178-8.
9
[Case of traditional herbal medicine-induced aristolochic acid nephropathy developing to end-stage renal failure].[传统草药所致马兜铃酸肾病进展至终末期肾衰竭病例]
Nihon Jinzo Gakkai Shi. 2005;47(4):474-80.
10
Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome.一名患有钙质沉着症、雷诺现象、食管功能障碍、指端硬化和毛细血管扩张症(CREST)综合征的患者因服用中药导致进行性间质性肾纤维化。
Intern Med. 2001 Oct;40(10):1059-63. doi: 10.2169/internalmedicine.40.1059.

引用本文的文献

1
Unveiling the Hidden Risks: Herbal Medicine-Induced Renal Damage - A Case Series Analysis.揭示潜在风险:草药引起的肾损伤——病例系列分析
Case Rep Nephrol Dial. 2025 Mar 21;15(1):60-69. doi: 10.1159/000545186. eCollection 2025 Jan-Dec.
2
Overview of aristolochic acid nephropathy: an update.马兜铃酸肾病概述:最新进展
Kidney Res Clin Pract. 2023 Sep;42(5):579-590. doi: 10.23876/j.krcp.22.211. Epub 2023 Jun 15.
3
Molecular Characterization of Microrna Interference and Aristolochic Acid Intoxication Found in Upper Tract Urothelial Carcinoma in Patients with Balkan Endemic Nephropathy: A Systematic Review of the Current Literature.
巴尔干地方性肾病患者上尿路尿路上皮癌中微小RNA干扰和马兜铃酸中毒的分子特征:当前文献的系统评价
Balkan J Med Genet. 2023 May 2;25(2):105-111. doi: 10.2478/bjmg-2022-0027. eCollection 2023 May.
4
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.含马兜铃酸的中草药与台湾地区上泌尿道尿路上皮癌:一篇叙述性评论。
World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22.
5
Aristolochic acid-associated cancers: a public health risk in need of global action.马兜铃酸相关癌症:亟待全球行动的公共健康风险。
Nat Rev Cancer. 2022 Oct;22(10):576-591. doi: 10.1038/s41568-022-00494-x. Epub 2022 Jul 19.
6
Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.马兜铃酸肾病小鼠模型组织黄嘌呤氧化还原酶活性。
FEBS Open Bio. 2021 Feb;11(2):507-518. doi: 10.1002/2211-5463.13083. Epub 2021 Feb 1.
7
Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents.马兜铃酸诱导的啮齿动物遗传毒性和毒理基因组变化
World J Tradit Chin Med. 2020 Jan-Mar;6(1):12-25. doi: 10.4103/wjtcm.wjtcm_33_19. Epub 2020 Mar 13.
8
[Evaluation of renal oxygenation in rats with acute aristolochic acid nephropathy using blood oxygenation level-dependent magnetic resonance imaging].[使用血氧水平依赖性功能磁共振成像评估大鼠急性马兜铃酸肾病的肾脏氧合情况]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 May 30;39(5):528-532. doi: 10.12122/j.issn.1673-4254.2019.05.05.
9
Worldwide research trends on aristolochic acids (1957-2017): Suggestions for researchers.全球关于马兜铃酸(1957-2017)的研究趋势:对研究人员的建议。
PLoS One. 2019 May 2;14(5):e0216135. doi: 10.1371/journal.pone.0216135. eCollection 2019.
10
Update of aristolochic acid nephropathy in Korea.韩国马兜铃酸肾病的最新情况。
Korean J Intern Med. 2018 Sep;33(5):961-969. doi: 10.3904/kjim.2016.288. Epub 2018 Mar 20.